Singapore
· Delayed Price · Currency is SGD Meta Health Statistics
Total Valuation
Meta Health has a market cap or net worth of SGD 6.60 million. The enterprise value is 8.16 million.
| Market Cap | 6.60M |
| Enterprise Value | 8.16M |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Meta Health has 1.32 billion shares outstanding. The number of shares has increased by 60.60% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.32B |
| Shares Change (YoY) | +60.60% |
| Shares Change (QoQ) | +60.60% |
| Owned by Insiders (%) | 19.25% |
| Owned by Institutions (%) | 17.67% |
| Float | 1.02B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.97 |
| PB Ratio | -3.91 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.66 |
| EV / Sales | 33.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.42
| Current Ratio | 0.42 |
| Quick Ratio | 0.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.17 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -5.81% |
| Return on Invested Capital (ROIC) | -13.76% |
| Return on Capital Employed (ROCE) | 35.47% |
| Revenue Per Employee | 284 |
| Profits Per Employee | -1,670 |
| Employee Count | 863 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.55% in the last 52 weeks. The beta is 0.72, so Meta Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -54.55% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 38.55 |
| Average Volume (20 Days) | 889,060 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Meta Health had revenue of SGD 244,828 and -1.44 million in losses. Loss per share was -0.00.
| Revenue | 244,828 |
| Gross Profit | 189,788 |
| Operating Income | -445,729 |
| Pretax Income | -1.05M |
| Net Income | -1.44M |
| EBITDA | -436,845 |
| EBIT | -445,729 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 598,451 in cash and 2.27 million in debt, giving a net cash position of -1.67 million or -0.00 per share.
| Cash & Cash Equivalents | 598,451 |
| Total Debt | 2.27M |
| Net Cash | -1.67M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -1.69M |
| Book Value Per Share | -0.00 |
| Working Capital | -1.65M |
Cash Flow
| Operating Cash Flow | -1.09M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 77.52% |
| Operating Margin | -182.06% |
| Pretax Margin | -429.80% |
| Profit Margin | n/a |
| EBITDA Margin | -178.43% |
| EBIT Margin | -182.06% |
| FCF Margin | n/a |
Dividends & Yields
Meta Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.60% |
| Shareholder Yield | -60.60% |
| Earnings Yield | -21.82% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Meta Health has an Altman Z-Score of -26.17. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.17 |
| Piotroski F-Score | n/a |